IRHYTHM HOLDINGS INC (IRTC) Fundamental Analysis & Valuation

NASDAQ:IRTC • US4500561067

Current stock price

120.8 USD
-8.36 (-6.47%)
At close:
120.8 USD
0 (0%)
After Hours:

This IRTC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IRTC Profitability Analysis

1.1 Basic Checks

  • In the past year IRTC has reported negative net income.
  • IRTC had a positive operating cash flow in the past year.
  • IRTC had negative earnings in each of the past 5 years.
  • In multiple years IRTC reported negative operating cash flow during the last 5 years.
IRTC Yearly Net Income VS EBIT VS OCF VS FCFIRTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • With a decent Return On Assets value of -4.37%, IRTC is doing good in the industry, outperforming 68.98% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -29.17%, IRTC is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
ROA -4.37%
ROE -29.17%
ROIC N/A
ROA(3y)-15.01%
ROA(5y)-18.57%
ROE(3y)-70.84%
ROE(5y)-59.45%
ROIC(3y)N/A
ROIC(5y)N/A
IRTC Yearly ROA, ROE, ROICIRTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • IRTC's Gross Margin of 70.57% is fine compared to the rest of the industry. IRTC outperforms 78.61% of its industry peers.
  • IRTC's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for IRTC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-0.81%
IRTC Yearly Profit, Operating, Gross MarginsIRTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. IRTC Health Analysis

2.1 Basic Checks

  • IRTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IRTC has more shares outstanding
  • Compared to 5 years ago, IRTC has more shares outstanding
  • Compared to 1 year ago, IRTC has an improved debt to assets ratio.
IRTC Yearly Shares OutstandingIRTC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IRTC Yearly Total Debt VS Total AssetsIRTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • IRTC has an Altman-Z score of 3.01. This indicates that IRTC is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of IRTC (3.01) is better than 67.38% of its industry peers.
  • The Debt to FCF ratio of IRTC is 18.81, which is on the high side as it means it would take IRTC, 18.81 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IRTC (18.81) is better than 68.45% of its industry peers.
  • A Debt/Equity ratio of 4.25 is on the high side and indicates that IRTC has dependencies on debt financing.
  • With a Debt to Equity ratio value of 4.25, IRTC is not doing good in the industry: 88.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 18.81
Altman-Z 3.01
ROIC/WACCN/A
WACC7.94%
IRTC Yearly LT Debt VS Equity VS FCFIRTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • IRTC has a Current Ratio of 4.63. This indicates that IRTC is financially healthy and has no problem in meeting its short term obligations.
  • IRTC has a Current ratio of 4.63. This is in the better half of the industry: IRTC outperforms 71.12% of its industry peers.
  • A Quick Ratio of 4.48 indicates that IRTC has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 4.48, IRTC is in the better half of the industry, outperforming 75.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.63
Quick Ratio 4.48
IRTC Yearly Current Assets VS Current LiabilitesIRTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

6

3. IRTC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.34% over the past year.
  • IRTC shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.24%.
  • The Revenue has been growing by 23.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)84.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.16%
Revenue 1Y (TTM)26.24%
Revenue growth 3Y22.05%
Revenue growth 5Y23.02%
Sales Q2Q%25.66%

3.2 Future

  • Based on estimates for the next years, IRTC will show a very strong growth in Earnings Per Share. The EPS will grow by 47.06% on average per year.
  • Based on estimates for the next years, IRTC will show a quite strong growth in Revenue. The Revenue will grow by 16.75% on average per year.
EPS Next Y74.01%
EPS Next 2Y66.08%
EPS Next 3Y53.37%
EPS Next 5Y47.06%
Revenue Next Year18.42%
Revenue Next 2Y17.17%
Revenue Next 3Y16.82%
Revenue Next 5Y16.75%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IRTC Yearly Revenue VS EstimatesIRTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
IRTC Yearly EPS VS EstimatesIRTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

2

4. IRTC Valuation Analysis

4.1 Price/Earnings Ratio

  • IRTC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • IRTC is valuated quite expensively with a Price/Forward Earnings ratio of 153.17.
  • Based on the Price/Forward Earnings ratio, IRTC is valued a bit cheaper than the industry average as 65.24% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. IRTC is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 153.17
IRTC Price Earnings VS Forward Price EarningsIRTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, IRTC is valued a bit cheaper than 67.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 113.1
EV/EBITDA N/A
IRTC Per share dataIRTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRTC does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as IRTC's earnings are expected to grow with 53.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.08%
EPS Next 3Y53.37%

0

5. IRTC Dividend Analysis

5.1 Amount

  • No dividends for IRTC!.
Industry RankSector Rank
Dividend Yield 0%

IRTC Fundamentals: All Metrics, Ratios and Statistics

IRHYTHM HOLDINGS INC

NASDAQ:IRTC (5/1/2026, 8:00:02 PM)

After market: 120.8 0 (0%)

120.8

-8.36 (-6.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.63
Earnings (Last)04-30
Earnings (Next)N/A
Inst Owners112.97%
Inst Owner Change0.12%
Ins Owners1.17%
Ins Owner Change1.25%
Market Cap3.90B
Revenue(TTM)747.14M
Net Income(TTM)-44.55M
Analysts86.67
Price Target200.47 (65.95%)
Short Float %9.52%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)408.63%
Min EPS beat(2)81.05%
Max EPS beat(2)736.22%
EPS beat(4)4
Avg EPS beat(4)214.01%
Min EPS beat(4)4.68%
Max EPS beat(4)736.22%
EPS beat(8)6
Avg EPS beat(8)106.43%
EPS beat(12)7
Avg EPS beat(12)59.14%
EPS beat(16)10
Avg EPS beat(16)48.17%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)1.59%
Max Revenue beat(2)2.36%
Revenue beat(4)4
Avg Revenue beat(4)2.65%
Min Revenue beat(4)1.42%
Max Revenue beat(4)5.22%
Revenue beat(8)6
Avg Revenue beat(8)1.4%
Revenue beat(12)8
Avg Revenue beat(12)1.15%
Revenue beat(16)10
Avg Revenue beat(16)0.88%
PT rev (1m)-4.21%
PT rev (3m)-7.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.08%
EPS NY rev (1m)0%
EPS NY rev (3m)11.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 153.17
P/S 5.23
P/FCF 113.1
P/OCF 48.28
P/B 25.56
P/tB 25.71
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)0.79
Fwd EY0.65%
FCF(TTM)1.07
FCFY0.88%
OCF(TTM)2.5
OCFY2.07%
SpS23.12
BVpS4.73
TBVpS4.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.37%
ROE -29.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.57%
FCFM 4.62%
ROA(3y)-15.01%
ROA(5y)-18.57%
ROE(3y)-70.84%
ROE(5y)-59.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-0.81%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 18.81
Debt/EBITDA N/A
Cap/Depr 223.42%
Cap/Sales 6.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.63
Quick Ratio 4.48
Altman-Z 3.01
F-Score6
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)235.65%
Cap/Depr(5y)242.93%
Cap/Sales(3y)7.56%
Cap/Sales(5y)7.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.16%
EPS Next Y74.01%
EPS Next 2Y66.08%
EPS Next 3Y53.37%
EPS Next 5Y47.06%
Revenue 1Y (TTM)26.24%
Revenue growth 3Y22.05%
Revenue growth 5Y23.02%
Sales Q2Q%25.66%
Revenue Next Year18.42%
Revenue Next 2Y17.17%
Revenue Next 3Y16.82%
Revenue Next 5Y16.75%
EBIT growth 1Y35.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year288.91%
EBIT Next 3Y79.08%
EBIT Next 5Y60.06%
FCF growth 1Y175.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2285.34%
OCF growth 3YN/A
OCF growth 5YN/A

IRHYTHM HOLDINGS INC / IRTC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IRHYTHM HOLDINGS INC (IRTC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IRTC.


What is the valuation status of IRHYTHM HOLDINGS INC (IRTC) stock?

ChartMill assigns a valuation rating of 2 / 10 to IRHYTHM HOLDINGS INC (IRTC). This can be considered as Overvalued.


How profitable is IRHYTHM HOLDINGS INC (IRTC) stock?

IRHYTHM HOLDINGS INC (IRTC) has a profitability rating of 2 / 10.


How financially healthy is IRHYTHM HOLDINGS INC?

The financial health rating of IRHYTHM HOLDINGS INC (IRTC) is 5 / 10.